BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17828388)

  • 1. Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure.
    Gastaldi G; Russell A; Golay A; Giacobino JP; Habicht F; Barthassat V; Muzzin P; Bobbioni-Harsch E
    Diabetologia; 2007 Nov; 50(11):2348-55. PubMed ID: 17828388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2.
    Soriano FX; Liesa M; Bach D; Chan DC; Palacín M; Zorzano A
    Diabetes; 2006 Jun; 55(6):1783-91. PubMed ID: 16731843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes involved in mitochondrial biogenesis/function are induced in response to bilio-pancreatic diversion in morbidly obese individuals with normal glucose tolerance but not in type 2 diabetic patients.
    Hernández-Alvarez MI; Chiellini C; Manco M; Naon D; Liesa M; Palacín M; Mingrone G; Zorzano A
    Diabetologia; 2009 Aug; 52(8):1618-27. PubMed ID: 19504086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?
    Mingrone G; Manco M; Calvani M; Castagneto M; Naon D; Zorzano A
    Diabetologia; 2005 Oct; 48(10):2108-14. PubMed ID: 16160866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity.
    Hernández-Alvarez MI; Thabit H; Burns N; Shah S; Brema I; Hatunic M; Finucane F; Liesa M; Chiellini C; Naon D; Zorzano A; Nolan JJ
    Diabetes Care; 2010 Mar; 33(3):645-51. PubMed ID: 20032281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.
    Bach D; Naon D; Pich S; Soriano FX; Vega N; Rieusset J; Laville M; Guillet C; Boirie Y; Wallberg-Henriksson H; Manco M; Calvani M; Castagneto M; Palacín M; Mingrone G; Zierath JR; Vidal H; Zorzano A
    Diabetes; 2005 Sep; 54(9):2685-93. PubMed ID: 16123358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids.
    Hoeks J; Hesselink MK; Russell AP; Mensink M; Saris WH; Mensink RP; Schrauwen P
    Diabetologia; 2006 Oct; 49(10):2419-26. PubMed ID: 16896940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes.
    Zorzano A; Hernández-Alvarez MI; Palacín M; Mingrone G
    Biochim Biophys Acta; 2010; 1797(6-7):1028-33. PubMed ID: 20175989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of mitofusin-2 expression in skeletal muscle.
    Zorzano A
    Appl Physiol Nutr Metab; 2009 Jun; 34(3):433-9. PubMed ID: 19448711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exonic peroxisome proliferator-activated receptor-γ coactivator-1α variation may mediate the resting energy expenditure through a potential regulatory role on important gene expression in this pathway.
    Mirzaei K; Hossein-nezhad A; Emamgholipour S; Ansar H; Khosrofar M; Tootee A; Alatab S
    J Nutrigenet Nutrigenomics; 2012; 5(2):59-71. PubMed ID: 22652814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.
    Camastra S; Gastaldelli A; Mari A; Bonuccelli S; Scartabelli G; Frascerra S; Baldi S; Nannipieri M; Rebelos E; Anselmino M; Muscelli E; Ferrannini E
    Diabetologia; 2011 Aug; 54(8):2093-102. PubMed ID: 21614570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet.
    Sesti G; Perego L; Cardellini M; Andreozzi F; Ricasoli C; Vedani P; Guzzi V; Marchi M; Paganelli M; Ferla G; Pontiroli AE; Hribal ML; Folli F
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5064-9. PubMed ID: 15985484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter.
    Sookoian S; Rosselli MS; Gemma C; Burgueño AL; Fernández Gianotti T; Castaño GO; Pirola CJ
    Hepatology; 2010 Dec; 52(6):1992-2000. PubMed ID: 20890895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential acute and chronic responses in insulin action in cultured myotubes following from nondiabetic severely obese humans following gastric bypass surgery.
    Hinkley JM; Zou K; Park S; Zheng D; Dohm GL; Houmard JA
    Surg Obes Relat Dis; 2017 Nov; 13(11):1853-1862. PubMed ID: 28673470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2.
    Zhang Y; Yang L; Gao YF; Fan ZM; Cai XY; Liu MY; Guo XR; Gao CL; Xia ZK
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):230-40. PubMed ID: 23954742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting energy expenditure after Roux-en Y gastric bypass surgery.
    Wilms B; Ernst B; Thurnheer M; Schmid SM; Spengler CM; Schultes B
    Surg Obes Relat Dis; 2018 Feb; 14(2):191-199. PubMed ID: 29275093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity.
    Flancbaum L; Choban PS; Bradley LR; Burge JC
    Surgery; 1997 Nov; 122(5):943-9. PubMed ID: 9369895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass.
    Kirchner H; Nylen C; Laber S; Barrès R; Yan J; Krook A; Zierath JR; Näslund E
    Surg Obes Relat Dis; 2014; 10(4):671-8. PubMed ID: 24837562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early reduction of resting energy expenditure and successful weight loss after Roux-en-Y gastric bypass.
    Moehlecke M; Andriatta Blume C; Rheinheimer J; Trindade MRM; Crispim D; Leitão CB
    Surg Obes Relat Dis; 2017 Feb; 13(2):204-209. PubMed ID: 27692914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In utero exposure to prepregnancy maternal obesity and postweaning high-fat diet impair regulators of mitochondrial dynamics in rat placenta and offspring.
    Borengasser SJ; Faske J; Kang P; Blackburn ML; Badger TM; Shankar K
    Physiol Genomics; 2014 Dec; 46(23):841-50. PubMed ID: 25336449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.